TY - JOUR
T1 - KRas4b-Calmodulin Interaction with Membrane Surfaces
T2 - Role of Headgroup, Acyl Chain, and Electrostatics
AU - Shree, Shweta
AU - McLean, Mark A.
AU - Stephen, Andrew G.
AU - Sligar, Stephen G.
N1 - This research is funded by a MIRA Grant from the National Institutes of Health (R35 GM118145). The authors are thankful for the insightful discussions and valuable suggestions provided by Dr. Ilia Denisov and Dr. Yelena Grinkova from the University of Illinois at Urbana-Champaign. The authors are also grateful for the training and access to Biolayer Interferometry (BLI) provided by Dr. Nicholas Wu and Dr. Ruipeng Lei. Work at the Frederick National Laboratory was funded by the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024. The content of this publication does not necessarily represent the views or policies of the Department of Health and Human Services, nor is there any endorsement from the U.S. Government by mentioning any trade names, commercial products, or organizations. Our sincere appreciation goes to the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research, under the leadership of Dr. Frank McCormick and Dr. Dwight Nissley, and their dedicated team members, for their pivotal collaboration. Special thanks are also due to Vanessa Wall, Kelly Snead, Shelley Perkins, William K Gillette, and Dominic Esposito for their role in producing the KRas4b-FME protein utilized in this study.
This research is funded by a MIRA Grant from the National Institutes of Health (R35 GM118145). The authors are thankful for the insightful discussions and valuable suggestions provided by Dr. Ilia Denisov and Dr. Yelena Grinkova from the University of Illinois at Urbana\u2013Champaign. The authors are also grateful for the training and access to Biolayer Interferometry (BLI) provided by Dr. Nicholas Wu and Dr. Ruipeng Lei. Work at the Frederick National Laboratory was funded by the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024. The content of this publication does not necessarily represent the views or policies of the Department of Health and Human Services, nor is there any endorsement from the U.S. Government by mentioning any trade names, commercial products, or organizations. Our sincere appreciation goes to the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research, under the leadership of Dr. Frank McCormick and Dr. Dwight Nissley, and their dedicated team members, for their pivotal collaboration. Special thanks are also due to Vanessa Wall, Kelly Snead, Shelley Perkins, William K Gillette, and Dominic Esposito for their role in producing the KRas4b-FME protein utilized in this study.
PY - 2024/11/5
Y1 - 2024/11/5
N2 - KRas4b is a small plasma membrane-bound G-protein that regulates signal transduction pathways. The interaction of KRas4b with the plasma membrane is governed by both its basic C-terminus, which is farnesylated and methylated, and the lipid composition of the membrane itself. The signaling activity of KRas4b is intricately related to its interaction with various binding partners at the plasma membrane, underlining the critical role played by the lipid environment. The calcium-binding protein calmodulin binds farnesylated KRas4b and plays an important role in the dynamic spatial cycle of KRas4b trafficking in the cell. We utilize Biolayer Interferometry to assay the role of lipid headgroup, chain length, and electrostatics in the dissociation kinetics of fully post-translationally modified KRas4b from Nanodisc bilayers with defined lipid compositions. Our results suggest that calmodulin promotes the dissociation of KRas4b from an anionic membrane, with a comparatively slower displacement of KRas4b from PIP2 relative to PS containing bilayers. In addition to this headgroup dependence, KRas4b dissociation appears to be slower from Nanodiscs wherein the lipid composition contains mismatched, unsaturated acyl chains as compared to lipids with a matched acyl chain length. These findings contribute to understanding the role of the lipid composition in the binding of KRas4b and release from lipid bilayers, showing that the overall charge of the bilayer, the identity of the headgroups present, and the length and saturation of the acyl chains play key roles in KRas4b release from the membrane, potentially providing insights in targeting Ras-membrane interactions for therapeutic interventions.
AB - KRas4b is a small plasma membrane-bound G-protein that regulates signal transduction pathways. The interaction of KRas4b with the plasma membrane is governed by both its basic C-terminus, which is farnesylated and methylated, and the lipid composition of the membrane itself. The signaling activity of KRas4b is intricately related to its interaction with various binding partners at the plasma membrane, underlining the critical role played by the lipid environment. The calcium-binding protein calmodulin binds farnesylated KRas4b and plays an important role in the dynamic spatial cycle of KRas4b trafficking in the cell. We utilize Biolayer Interferometry to assay the role of lipid headgroup, chain length, and electrostatics in the dissociation kinetics of fully post-translationally modified KRas4b from Nanodisc bilayers with defined lipid compositions. Our results suggest that calmodulin promotes the dissociation of KRas4b from an anionic membrane, with a comparatively slower displacement of KRas4b from PIP2 relative to PS containing bilayers. In addition to this headgroup dependence, KRas4b dissociation appears to be slower from Nanodiscs wherein the lipid composition contains mismatched, unsaturated acyl chains as compared to lipids with a matched acyl chain length. These findings contribute to understanding the role of the lipid composition in the binding of KRas4b and release from lipid bilayers, showing that the overall charge of the bilayer, the identity of the headgroups present, and the length and saturation of the acyl chains play key roles in KRas4b release from the membrane, potentially providing insights in targeting Ras-membrane interactions for therapeutic interventions.
UR - http://www.scopus.com/inward/record.url?scp=85206471646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85206471646&partnerID=8YFLogxK
U2 - 10.1021/acs.biochem.4c00116
DO - 10.1021/acs.biochem.4c00116
M3 - Article
C2 - 39382513
AN - SCOPUS:85206471646
SN - 0006-2960
VL - 63
SP - 2740
EP - 2749
JO - Biochemistry
JF - Biochemistry
IS - 21
ER -